TacrolimusBurning sensation secondary to off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1729卷 / 1期

关键词：

D O I：

10.1007/s40278-018-54881-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：251 / 251

相关论文

共 50 条

[1] DexamethasoneAspergillosis secondary to off-label use: case report
Reactions Weekly, 2022, 1935 (1) : 177 - 177
[2] SpironolactoneHyperkalaemia secondary to off-label use: case report
Reactions Weekly, 2021, 1836 (1) : 710 - 710
[3] OsimertinibPneumonitis secondary to off-label use: case report
Reactions Weekly, 2020, 1814 (1) : 283 - 283
[4] KetamineLoss of temperature sensation during off-label use: case report
Reactions Weekly, 2017, 1675 (1) : 144 - 144
[5] Multiple drugsHypoglycaemia secondary to off-label use: case report
Reactions Weekly, 2020, 1816 (1) : 228 - 228
[6] EmpagliflozinDiabetic ketoacidosis secondary to off-label use: case report
Reactions Weekly, 2019, 1756 (1) : 145 - 145
[7] ClopidogrelNose bleed secondary to off-label use: case report
Reactions Weekly, 2019, 1751 (1) : 106 - 106
[8] QuetiapinePancreatitis secondary to hypertriglyceridaemia and off-label use: case report
Reactions Weekly, 2018, 1720 (1) : 219 - 219
[9] MinocyclineAnaphylactic shock secondary to off-label use: case report
Reactions Weekly, 2019, 1768 (1) : 230 - 230
[10] TocilizumabInfusion reaction secondary to off-label use: case report
Reactions Weekly, 2019, 1766 (1) : 281 - 281

← 1 2 3 4 5 →